Pharming Group (PHAR)
10.00
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
Pharming Group Price to Book Value: 3.078 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 3.078 |
| May 02, 2024 | 3.078 |
| May 01, 2024 | 3.217 |
| April 30, 2024 | 3.007 |
| April 29, 2024 | 3.050 |
| April 26, 2024 | 3.017 |
| April 25, 2024 | 3.217 |
| April 24, 2024 | 3.026 |
| April 23, 2024 | 2.955 |
| April 22, 2024 | 3.054 |
| April 19, 2024 | 3.078 |
| April 18, 2024 | 2.872 |
| April 17, 2024 | 3.130 |
| April 16, 2024 | 3.130 |
| April 15, 2024 | 3.318 |
| April 12, 2024 | 3.241 |
| April 11, 2024 | 3.478 |
| April 10, 2024 | 3.226 |
| April 09, 2024 | 3.078 |
| April 08, 2024 | 3.278 |
| April 05, 2024 | 3.263 |
| April 04, 2024 | 3.290 |
| April 03, 2024 | 3.374 |
| April 02, 2024 | 3.312 |
| April 01, 2024 | 3.474 |
| Date | Value |
|---|---|
| March 28, 2024 | 3.325 |
| March 27, 2024 | 3.325 |
| March 26, 2024 | 3.328 |
| March 25, 2024 | 3.457 |
| March 22, 2024 | 3.457 |
| March 21, 2024 | 3.374 |
| March 20, 2024 | 3.374 |
| March 19, 2024 | 3.374 |
| March 18, 2024 | 3.527 |
| March 15, 2024 | 3.524 |
| March 14, 2024 | 3.350 |
| March 13, 2024 | 3.408 |
| March 12, 2024 | 3.644 |
| March 11, 2024 | 3.573 |
| March 08, 2024 | 3.529 |
| March 07, 2024 | 3.435 |
| March 06, 2024 | 3.435 |
| March 05, 2024 | 3.423 |
| March 04, 2024 | 3.616 |
| March 01, 2024 | 3.487 |
| February 29, 2024 | 3.512 |
| February 28, 2024 | 3.405 |
| February 27, 2024 | 3.423 |
| February 26, 2024 | 3.460 |
| February 23, 2024 | 3.604 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.208
Minimum
Jun 16 2022
6.661
Maximum
Dec 23 2020
3.642
Average
3.658
Median
Nov 17 2023
Price to Book Value Benchmarks
| uniQure NV | 1.080 |
| ProQR Therapeutics NV | 3.574 |
| Merus NV | 7.916 |
| argenx SE | 5.630 |
| Pharvaris NV | 2.865 |
Price to Book Value Related Metrics
| PS Ratio | 2.957 |
| Price | 10.00 |
| Earnings Yield | -1.60% |
| Market Cap | 673.44M |